Ocugen, Inc. (OCGN) stock
OCGNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$0.76−0.02 (-2.11%)
Close on Nov 17, 2026Market cap $256.61MP/E –Yield –
Ocugen market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Ocugen's market cap was $325.62M on Nov 11, 2026, against $387.28M a year earlier. Over the last 5 years it ranged from $94.36M to $905.12M, with a median of $338.03M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $325.62M | -22.8% |
| 2025 | Dec 31, 2025 | $421.63M | +80.4% |
| 2024 | Dec 31, 2024 | $233.66M | +58.4% |
| 2023 | Dec 29, 2023 | $147.49M | -47.6% |
| 2022 | Dec 30, 2022 | $281.69M | -68.9% |
| 2021 | Dec 31, 2021 | $905.12M | +205.3% |
| 2020 | Dec 31, 2020 | $296.51M | +5594.3% |
| 2019 | Dec 31, 2019 | $5.21M | -83.2% |
| 2018 | Dec 31, 2018 | $30.94M | -93.4% |
| 2017 | Dec 29, 2017 | $467.12M | +76.3% |
| 2016 | Dec 30, 2016 | $265.01M | -43.0% |
| 2015 | Dec 31, 2015 | $464.57M | – |
See a number that looks wrong?